ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This research is being done to find out more information about a brain tumor called Embryonal Tumor with Multilayer Rosettes (ETMR) by collecting medical information from children who have this disease. The purpose of this research study is to create and maintain a research database for patients with ETMR. The database will include information about occurrence rates, patient information, tumor tissue information, and response to treatment. This will help advance our understanding of this rare disease. In addition, this study will include obtaining survival data and evaluating therapeutic response to expert consensus therapy, and procuring patient tumor tissue.

Eligibility
Participation Requirements
Sex: All
View:

• Patients of any age

• Patients must have either a histologically confirmed primary intracranial CNS Embryonal Tumor with Multilayer Rosettes (as agreed upon by central review or local pathologist OR

• Patients must have tumor tissue that possesses C19MC amplification . Central Review is not required (but is strongly recommended) if the patient's tumor does not demonstrate C19MC amplification.

• Patients may be enrolled at point following diagnosis

Locations
United States
New Jersey
Hackensack University Medical Center
RECRUITING
Hackensack
Contact Information
Primary
Derek Hanson, MD
Derek.Hanson@HMHN.org
551-996-8437
Backup
Kellie Daniel, BA
Kellie.daniel@HMHN.org
551-996-3654
Time Frame
Start Date: 2020-07-12
Estimated Completion Date: 2030-07-12
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Hackensack Meridian Health

This content was sourced from clinicaltrials.gov